After-Hours Stock Movers 07/15: (RTIX) (DELL) (AA) Higher; (TCDA) (CYTK) (TWTR) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cytokinetics (CYTK) Prices 7.29M Share Common Offering at $24/Sh
July 17, 2020 5:56 AM EDTCytokinetics, Incorporated (NASDAQ: CYTK) today announced the pricing of an underwritten public offering of 7,291,667 shares of its common stock at a price to the public of $24.00 per share, before underwriting discounts and commissions. The gross proceeds to Cytokinetics from the offering, before deducting underwriting... More
Raymond James Reiterates Market Perform Rating on Sleep Number (SNBR) Following 2Q
July 16, 2020 7:19 AM EDTRaymond James analyst Bobby Griffin reiterated a Market Perform rating on Sleep Number (NASDAQ: SNBR) following the company's 2Q earnings report. EPS of $(0.45) beat the $(0.61) consensus. Sales decreased ~20% y/y to ~$285 million, above the consensus of $251 million.
Reflecting the better than anticipated recovery,... More
